GAPDH Inhibitor Compound F8

GAPDH Inhibitor Compound F8
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay42090-1 1 mg - -

5 - 10 business days*

55.00€
Cay42090-5 5 mg - -

5 - 10 business days*

243.00€
 
A covalent inhibitor of GAPDH (IC50 = 39.31 µM), decreases viability of, and glucose metabolism... more
Product information "GAPDH Inhibitor Compound F8"
A covalent inhibitor of GAPDH (IC50 = 39.31 µM), decreases viability of, and glucose metabolism in, HEK293 cells in a concentration-dependent manner. Formulation: A solid. InChI: InChI=1S/C20H18N2O5/c1-3-13(7-15(5-1)23-9-17-11-25-17)19-21-22-20(27-19)14-4-2-6-16(8-14)24-10-18-12-26-18/h1-8,17-18H,9-12H2. InChIKey: IQCCNCOQRRJSTE-UHFFFAOYSA-N. SMILES: C1(C2=CC(OCC3OC3)=CC=C2)=NN=C(C4=CC=CC(OCC5CO5)=C4)O1
Keywords: 2,5-bis[3-(2-oxiranylmethoxy)phenyl]-1,3,4-oxadiazole
Supplier: Cayman Chemical
Supplier-Nr: 42090

Properties

Application: GAPDH covalent inhibitor
Immunogen: 366.37
MW: 366.37 D
Formula: C20H18N2O5
Purity: >95%
Format: Solid

Database Information

CAS : 252212-58-1| Matching products
KEGG ID : K00134 | Matching products

Handling & Safety

Storage: -20°C
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GAPDH Inhibitor Compound F8"
Write a review
or to review a product.
Viewed